Literature DB >> 16492936

Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial.

Marcus R Munafò1, Elaine C Johnstone, E Paul Wileyto, Peter G Shields, Katherine M Elliot, Caryn Lerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16492936     DOI： 10.1158/1055-9965.EPI-05-0648

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  22 in total

Review 1.  Genetics and smoking cessation improving outcomes in smokers at risk.

Authors:  Caryn E Lerman; Robert A Schnoll; Marcus R Munafò
Journal:  Am J Prev Med       Date:  2007-12       Impact factor: 5.043

2.  The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial.

Authors:  Sean P David; Marcus R Munafò; Michael F G Murphy; Robert T Walton; Elaine C Johnstone
Journal:  Nicotine Tob Res       Date:  2007-02       Impact factor: 4.244

Review 3.  Genetics and smoking behavior.

Authors:  Robert A Schnoll; Terrance A Johnson; Caryn Lerman
Journal:  Curr Psychiatry Rep       Date:  2007-10       Impact factor: 5.285

4.  Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.

Authors:  Sean P David; Elaine C Johnstone; Michael F G Murphy; Paul Aveyard; Boliang Guo; Caryn Lerman; Marcus R Munafò
Journal:  Drug Alcohol Depend       Date:  2008-06-17       Impact factor: 4.492

5.  CHRNA3 rs1051730 genotype and short-term smoking cessation.

Authors:  Marcus R Munafò; Elaine C Johnstone; Donna Walther; George R Uhl; Michael F G Murphy; Paul Aveyard
Journal:  Nicotine Tob Res       Date:  2011-06-20       Impact factor: 4.244

Review 6.  Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials.

Authors:  Sean P David; Elaine C Johnstone; Michael Churchman; Paul Aveyard; Michael F G Murphy; Marcus R Munafò
Journal:  Nicotine Tob Res       Date:  2011-01-25       Impact factor: 4.244

Review 7.  A review of pharmacogenetic studies of substance-related disorders.

Authors:  Jermaine D Jones; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2015-03-18       Impact factor: 4.492

Review 8.  Genetic polymorphism of serotonin transporter 5-HTTLPR: involvement in smoking behaviour.

Authors:  Maria Angelica Ehara Watanabe; Sandra Odebrecht Vargas Nunes; Sandra Odebrechet Vargas Nunes; Marla Karine Amarante; Roberta Losi Guembarovski; Julie Massayo Maeda Oda; Kalil William Alves De Lima; Maria Helena Pelegrinelli Fungaro
Journal:  J Genet       Date:  2011-04       Impact factor: 1.166

Review 9.  Pharmacogenetics and smoking cessation with nicotine replacement therapy.

Authors:  Riju Ray; Robert A Schnoll; Caryn Lerman
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

10.  Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood.

Authors:  Kenneth A Perkins; Caryn Lerman; Amy Grottenthaler; Melinda M Ciccocioppo; Melissa Milanak; Cynthia A Conklin; Andrew W Bergen; Neal L Benowitz
Journal:  Behav Pharmacol       Date:  2008-09       Impact factor: 2.293
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.